Biomano will participate in the 2d International Congress on Sickle Cell Disease and in the 7th International Symposium on Sickle Cell Disease in Central Africa (REDAC)

An event dedicated to the Sickle Cell Disease strategy for the WHO African Region. Biomaneo will present:

  1. The results of the feasibility study performed in Madagascar in 2017 with its kits for the sickle cell disease screening using mass spectrometry. A study carried out in collaboration with the HJRA Hospital, the Institut Pasteur and the LCDM SOLIMAD from Madagascar.
  2. The innovative product developed by the cluster Biomaneo/Calao to offer both detection and therapeutic education to the population concerned by the sickle cell disease in the African countries. A program conducted in collaboration with the Yopougon Hospital and the Institut Pasteur in Abidjan.